The Indian Society for Clinical Research (ISCR) has developed a causality assessment portal in collaboration with Harvard University's Multi-Regional Clinical Trials (MRCT) Center which it hopes will facilitate a more “reasoned” evaluation of the likelihood of a causal connection between an investigational medicine and an adverse event in trials.
An endorsement of the tool by the country's regulators (and there are some encouraging early signs) could, alongside other ongoing...




